Orilissa Dosage

2.1 Important Dosing Information

• Exclude pregnancy before starting ORILISSA or start ORILISSA within 7 days from the onset of menses.
  
• Take ORILISSA at approximately the same time each day, with or without food.
  
• Use the lowest effective dose, taking into account the severity of symptoms and treatment objectives.
  
• Limit the duration of use because of bone loss (Table 1).

2.2 Hepatic Impairment

No dosage adjustment of ORILISSA is required in women with mild hepatic impairment (Child-Pugh A).

Compared to women with normal liver function, those with moderate hepatic impairment had approximately 3-fold higher elagolix exposures and those with severe hepatic impairment had approximately 7-fold higher elagolix exposures. Because of these increased exposures and risk for bone loss:

• ORILISSA 150 mg once daily is recommended for women with moderate hepatic impairment (Child-Pugh B) with the duration of treatment limited to 6 months. Use of ORILISSA 200 mg twice daily is not recommended for women with moderate hepatic impairment.
  
• ORILISSA is contraindicated in women with severe hepatic impairment (Child-Pugh C).

2.3 Missed Dose

Instruct the patient to take a missed dose of ORILISSA on the same day as soon as she remembers and then resume the regular dosing schedule.

• 150 mg once daily: take no more than 1 tablet each day.
  
• 200 mg twice daily: take no more than 2 tablets each day.